EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS

Non-alcoholic fatty liver disease (NAFLD) is a group of conditions closely associated with obesity that are among the most common and socially significant liver diseases in the modern Western world. The emergence and progression of NAFLD from simple steatosis to non-alcoholic steatohepatitis with th...

Full description

Bibliographic Details
Published in:	Медицинская иммунология
Main Authors:	A. V. Bogolyubova, E. E. Mishina, P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, A. Yu. Mayorov, P. V. Belousov
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2019-12-01
Subjects:	toll-like receptors proinflammatory cytokines nonalcoholic fatty liver disease nonalcoholic steatohepatitis steatosis
Online Access:	https://www.mimmun.ru/mimmun/article/view/1617

Similar Items

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
by: Ekaterina E. Mishina, et al.
Published: (2017-12-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
by: Apollinariya V. Bogolyubova, et al.
Published: (2017-12-01)

Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling.
by: A. Yu. Filippova, et al.
Published: (2017-12-01)

A look at new therapeutic opportunities in patients with non-alcoholic fatty liver disease
by: Ekaterina E. Mishina, et al.
Published: (2019-12-01)

Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
by: Wasitha P. D. W. Thilakarathna, et al.
Published: (2024-02-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
by: Sadatsugu Sakane, et al.
Published: (2021-01-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

Modern diagnostics of nonalcoholic fatty liver disease: noninvasive research methods
by: N. M. Palibroda
Published: (2016-08-01)

Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patient with nonalcoholic fatty liver diseas
by: Stergios A. Polyzos, et al.
Published: (2016-09-01)

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
by: Karima Begriche, et al.
Published: (2023-01-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

The long‐term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high‐fructose‐fed adolescent rats
by: Kasimu G. Ibrahim, et al.
Published: (2019-03-01)

Features of Glucose Homeostasis and Blood Lipid Spectrum in Patients with Nonalcoholic Fatty Liver Dis ease Depending on the Obesity Degree
by: Korniichuk I., et al.
Published: (2019-04-01)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Ji-Young Cha, et al.
Published: (2018-12-01)

Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies
by: Farnush Bakhshimoghaddam, et al.
Published: (2024-11-01)

Association of insulin resistance and non-alcoholic fatty liver disease
by: Ekaterina E. Mishina, et al.
Published: (2021-01-01)

Features of eating behavior in children with different forms of non-alcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2021-09-01)

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014-09-01)

Nonalcoholic fatty liver disease
by: Lafaine M. Grant, et al.
Published: (2004-07-01)

Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
by: Raptis DD, et al.
Published: (2023-01-01)

SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate CellsSummary
by: Xiaolin Zhong, et al.
Published: (2020-01-01)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2022-09-01)

Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
by: V. T. Ivashkin, et al.
Published: (2025-03-01)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2023-09-01)

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
by: Andrew A. Li, et al.
Published: (2020-03-01)

Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral Hepatitis
by: Mohamed Salaheldin, et al.
Published: (2023-08-01)

Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy
by: Reeju Amatya, et al.
Published: (2023-07-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01)

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
by: Georgiana-Emmanuela Gîlcă-Blanariu, et al.
Published: (2023-10-01)

CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
by: Ha Neul Kim, et al.
Published: (2023-03-01)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
by: Ho Soo Chun, et al.
Published: (2023-04-01)

SYSTEMATIC REVIEW WITH COMPARATIVE ANALYSIS OF RECOMMENDATIONS FOR THE DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE
by: N.A. TOKTOGULOVA
Published: (2021-03-01)

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
by: Alessandro Mantovani, et al.
Published: (2020-12-01)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
by: Alexandra C. Finney, et al.
Published: (2023-05-01)

Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial
by: Han Ah Lee, et al.
Published: (2023-08-01)

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis
by: Yuki Tsuji, et al.
Published: (2020-06-01)